Point72 Asset Management »

Summit Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $54M 3.7M 14.57
2026-03-31 $15M 801k 18.96

More positions owned by Point72 Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Amazon (AMZN)
Asml Hldg Nv N Y Registry Shs (ASML)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Procter & Gamble Company (PG)
Arista Networks Com Shs (ANET)
MKS Instruments (MKSI)
Seagate Technology Hldngs Pl Ord Shs (STX)
Snowflake Com Shs (SNOW)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Oracle Corporation (ORCL)
Raytheon Technologies Corp (RTX)
Broadcom (AVGO)

View all positions for Point72 Asset Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Vanguard Capital Management
UBS Group
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Susquehanna International
Millennium Management
Adage Capital Partners GP

View all funds holding Summit Therapeutics